Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625

Disease

Influenza 3 | 142
cystic fibrosis 3 | 1,665
lung cancer 3 | 4,466
medulloblastoma, large-cell 3 | 6,234
ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
Allergic hypersensitivity disease 2 | 123
Arthritis 2 | 248
Aspergillosis 2 | 23
Asthma 2 | 349
Atherosclerosis 2 | 275
Breast cancer 2 | 3,094
Cancer 2 | 2,346
Chorioamnionitis 2 | 15
Chronic obstructive pulmonary disease 2 | 146
Colorectal Neoplasms 2 | 217
Dermatitis 2 | 107
Human immunodeficiency virus infectious disease 2 | 92
Hypersensitivity reaction type II disease 2 | 235
IGA Glomerulonephritis 2 | 454
Inflammation 2 | 109
Inflammatory bowel disease 2 | 142
Keratitis 2 | 42
Kidney disease 2 | 396
Leishmaniasis 2 | 49
Leptospirosis 2 | 17
Liver disease 2 | 219
Malaria 2 | 140
Mastitis 2 | 48
Meningitis 2 | 46
Multiple Sclerosis 2 | 498
Obesity 2 | 616
Otitis media 2 | 32
Perinatal necrotizing enterocolitis 2 | 18
Peritonitis 2 | 37
Pneumonia 2 | 133
Reperfusion Injury 2 | 84
Rheumatoid Arthritis 2 | 1,160
cutaneous lupus erythematosus 2 | 1,056
diabetes mellitus 2 | 1,663
fibroadenoma 2 | 557
glioblastoma 2 | 5,572
group 4 medulloblastoma 2 | 1,875
lung adenocarcinoma 2 | 2,713
lung carcinoma 2 | 2,844
malignant mesothelioma 2 | 3,162
pancreatic cancer 2 | 2,300
periodontitis 2 | 269
pilocytic astrocytoma 2 | 3,086
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087
Acute cystitis 1 | 37
Adenocarcinoma Of Esophagus 1 | 14
Age related macular degeneration 1 | 84
Brain disease 1 | 83
Candidiasis 1 | 48
Cardiomyopathies 1 | 90
Cerebrovascular disease 1 | 231
Chlamydia 1 | 18
Common cold 1 | 63
Coronary artery disease 1 | 240
Crohn Disease 1 | 97
Endometriosis 1 | 535
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Filariasis 1 | 21
Gastritis 1 | 44
Gaucher disease type 3 1 | 76
Heart disease 1 | 279
Hyperglycemia 1 | 120
Hypertension 1 | 287
Keratoconjunctivitis sicca 1 | 19
Leprosy 1 | 77
Lung Injury 1 | 20
Lung Neoplasms 1 | 171
Lyme disease 1 | 23
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) 1 | 12
Melanoma 1 | 261
Metabolic syndrome X 1 | 155
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Neurodegenerative disease 1 | 383
Pancreatitis 1 | 97
Parasitic helminthiasis infectious disease 1 | 13
Peripheral Neuropathy 1 | 303
Pertussis 1 | 17
Respiratory Hypersensitivity 1 | 18
Rhinitis 1 | 46
Sepsis 1 | 21
Spina bifida occulta 1 | 7
Tularemia 1 | 22
Vasculitis 1 | 64
adrenocortical carcinoma 1 | 1,427
atypical teratoid/rhabdoid tumor 1 | 1,095
hearing impairment 1 | 40
hepatocellular carcinoma 1 | 532
nasopharyngeal carcinoma 1 | 1,056
ovarian neoplasm 1 | 97
pancreatic carcinoma 1 | 567
systemic lupus erythematosus 1 | 156

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 3 | 11,971

Grant Application

5R01HD061918-04 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interferon-induced protein with tetratricopeptide repeats 1 IFIT1 Tbio Non-IDG -1.92869 85.7 133
Toll-like receptor 4 TLR4 Tchem Non-IDG -3.73821 6171.6 1142
Toll-like receptor 2 TLR2 Tchem Non-IDG -3.44411 3173.5 946